Taken together, our data identify a novel role for FKBP52 in Alzheimer's disease, and suggests that this high molecular weight immunophilin acts on multiple aspects of Aβ metabolism and toxicity. Here, FKBP4 is linked to early-onset autosomal dominant Alzheimer disease.